ID

22954

Description

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM; ODM derived from: https://clinicaltrials.gov/show/NCT00515801

Link

https://clinicaltrials.gov/show/NCT00515801

Keywords

Versions (1)
  1. 6/18/17 6/18/17 -
Uploaded on

June 18, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 1 NCT00515801

English

Eligibility Diabetes Mellitus, Type 1 NCT00515801

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged 18 to 50 years
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patients diagnosed with c-peptide negative diabetes type 1 (c-peptide <200 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1,1]
C0202100
UMLS CUI [1,2]
C0011854
UMLS CUI [1,3]
C2584434
patients diagnosed with c-peptide positive diabetes type 1 (c-peptide > 500 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0202100
UMLS CUI [1,2]
C0011854
UMLS CUI [1,3]
C2584434
stable metabolic control; hba1c levels <8.0 % and without episodes of antecedent severe hypoglycemias in the past four weeks
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C0150254
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated with medications potentially interfering with glucose metabolism, such as systemic steroids, immunosuppressive drugs (cyclosporine, tacrolimus, sirolimus), highly active antiretroviral therapy
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0021081
history coronary artery disease
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C1956346
history of epilepsy or seizures
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C0014544
UMLS CUI [1,2]
C0036572
current smokers
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0337664
any significant or unstable hepatic, cardiac, pulmonary, renal, neurological, musculoskeletal, hematological or endocrine disease.
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C0012634
pregnant or breast feeding women
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
woman of childbearing potential not using a reliable method of birth control such as oral contraceptives or iud.
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0009862
subjects refusing or unable to give written informed consent
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type 1 NCT00515801

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients aged 18 to 50 years
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
patients diagnosed with c-peptide negative diabetes type 1 (c-peptide <200 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
boolean
C0202100 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
ID.3
Item
patients diagnosed with c-peptide positive diabetes type 1 (c-peptide > 500 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
boolean
C0202100 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
ID.4
Item
stable metabolic control; hba1c levels <8.0 % and without episodes of antecedent severe hypoglycemias in the past four weeks
boolean
C0019018 (UMLS CUI [1,1])
C0150254 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
ID.5
Item
patients treated with medications potentially interfering with glucose metabolism, such as systemic steroids, immunosuppressive drugs (cyclosporine, tacrolimus, sirolimus), highly active antiretroviral therapy
boolean
C0038317 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
ID.6
Item
history coronary artery disease
boolean
C1956346 (UMLS CUI [1])
ID.7
Item
history of epilepsy or seizures
boolean
C0014544 (UMLS CUI [1,1])
C0036572 (UMLS CUI [1,2])
ID.8
Item
current smokers
boolean
C0337664 (UMLS CUI [1])
ID.9
Item
any significant or unstable hepatic, cardiac, pulmonary, renal, neurological, musculoskeletal, hematological or endocrine disease.
boolean
C0012634 (UMLS CUI [1])
ID.10
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.11
Item
woman of childbearing potential not using a reliable method of birth control such as oral contraceptives or iud.
boolean
C0009862 (UMLS CUI [1])
ID.12
Item
subjects refusing or unable to give written informed consent
boolean
C0021430 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial